Hennion & Walsh Asset Management, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1861642
Parsippany, NJ
Position in GILD
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$3,601,574
-$199,324 QoQ
Shares Held
28,507
+4.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#664
of 2,266 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $55,949,166 across 10 Drug Manufacturers - General names. GILD ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,360 | $17,223,816 | |
| 2 | JNJ |
Johnson & Johnson
|
43,755 | $11,112,457 | |
| 3 | MRK |
Merck & Co., Inc.
|
72,515 | $9,318,177 | |
| 4 | ABBV |
AbbVie Inc.
|
23,832 | $5,997,084 | |
| 5 | GRFS |
Grifols SA
|
592,173 | $4,192,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
28,507 | $3,601,574 | |
| 7 | AMGN |
Amgen Inc
|
7,665 | $2,775,649 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,045 | $1,039,752 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,601,574 | 28,507 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $3,800,898 | 27,272 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,627,372 | 21,406 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,011,098 | 18,118 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,398,292 | 12,612 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,387,179 | 12,380 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,037,961 | 11,237 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,414,380 | 16,870 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,681,905 | 24,514 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,090,848 | 28,544 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,832,028 | 34,959 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,663,142 | 35,537 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,835,174 | 36,787 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,034,129 | 36,569 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,908,426 | 33,878 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,665,506 | 26,998 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,254,866 | 20,302 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $760,008 | 12,784 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $574,635 | 7,914 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $390,391 | 5,589 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $352,907 | 5,125 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $307,315 | 4,755 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||